There are facilities (public and private) that can perform comprehensive genetic testing (genetic panels) on tumor specimens to characterize the above entities and more, e.g. the Genomics Research Core at the University of Pittsburgh, or FoundationOne CDx. Brain-specific profiles are also marketed, e.g. NeoTYPE Brain Tumor Profile by NeoGenomics, Fort Myers, Florida, which includes: ATRX, BRAF, EGFR, IDH1, IDH2, MGMT Promoter Methylation analysis (PCR), PTEN, TERT Promoter, TP53, 1p/19q co-deletion, and many others. Cost is on the order of $2000–4000U.S., turnaround time ≈ 2 weeks.